You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paliperidone extended-release

Showing 1 - 25 of 8,427
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenics Trial (Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular

Completed
  • Schizophrenics
  • Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega]
  • Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA]
  • (no location specified)
Feb 12, 2021

Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with

Not yet recruiting
  • Cannabis Use Disorder
  • Guanfacine Extended Release Oral Tablet
  • +3 more
  • Parkville, Victoria, Australia
    Orygen
Jul 16, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Opioid Use Disorder Trial (Buprenorphine Extended-Release Injection)

Not yet recruiting
  • Opioid Use Disorder
  • Buprenorphine Extended-Release Injection
  • (no location specified)
Feb 2, 2023

Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)

Not yet recruiting
  • Cocaine Use Disorder
  • Extended-Release Naltrexone
  • +2 more
  • (no location specified)
Jul 15, 2022

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet

Completed
  • End Stage Renal Disease
  • Rejection of Renal Transplant
  • Tacrolimus
  • Tacrolimus Extended Release Oral Tablet [Envarsus]
  • Chicago, Illinois
    Northwestern University
Jan 12, 2023

Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Somatic Symptom
  • toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
May 6, 2023

Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)

Not yet recruiting
  • Epilepsy
  • Lacosamide Tablets
  • Lacosamide extended release tablets
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023

Opioid Use Disorder Trial in New York (Extended-Release Buprenorphine (XRB), Sublingual Buprenorphine (SLB))

Not yet recruiting
  • Opioid Use Disorder
  • Extended-Release Buprenorphine (XRB)
  • Sublingual Buprenorphine (SLB)
  • New York, New York
    NYU Langone Health - 180 Madison Ave
Sep 18, 2023

Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)

Recruiting
  • Healthy
  • RPV LA
  • CAB LA
  • Lenexa, Kansas
  • +2 more
Jan 17, 2023

Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

Recruiting
  • Migraine Prophylaxis
  • Nicotinic Acid 500 MG Extended Release Oral Tablet
  • +2 more
  • Dhaka, Bangladesh
    BSMMU
May 5, 2023

Rotator Cuff Tears, Rotator Cuff Tendinitis, Rotator Cuff Impingement Trial in Great Neck (FX006 Injection)

Recruiting
  • Rotator Cuff Tears
  • +4 more
  • FX006 Injection
  • Great Neck, New York
    Northwell Health Orthopedic Institute at Great Neck
Dec 27, 2022

Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)

Recruiting
  • Lung Carcinoma
  • Biopsy
  • +4 more
  • Aurora, Colorado
  • +2 more
Jan 28, 2023

Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

Recruiting
  • Healthy
  • BLU-5937 IR
  • BLU-5937 ER
  • Nottingham, England, United Kingdom
    Quotient Sciences
Oct 4, 2022

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Opioid-Use Disorder, Opioid Overdose Trial in Vancouver

Recruiting
  • Opioid-Use Disorder
  • Opioid Overdose
    • Vancouver, British Columbia, Canada
      Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital
    Nov 16, 2022

    Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

    Completed
    • Healthy
    • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
    • +2 more
    • Cairo, Egypt
      Genuine Research Center GRC
    Mar 2, 2023

    Opioid-use Disorder Trial in New York (extended-release buprenorphine (BXR), sublingual buprenorphine (BSL))

    Recruiting
    • Opioid-use Disorder
    • extended-release buprenorphine (BXR)
    • sublingual buprenorphine (BSL)
    • New York, New York
      Nyspi-Stars
    Sep 29, 2022